Noora (vaccine)
Noora (Persian: نورا) is a COVID-19 vaccine candidate developed by Baqiyatallah University of Medical Sciences in collaboration with Plasma Darman Sarv Sepid Co. (lit. White Cypress Plasma Treatment) in Iran.[1][2]
Medical uses[edit]
It requires three doses given by intramuscular injection on days 0, 21 and 35.[3]
Pharmacology[edit]
Noora is a recombinant RBD protein subunit vaccine.[3]